In:
BioMed Research International, Hindawi Limited, Vol. 2021 ( 2021-9-17), p. 1-8
Abstract:
Introduction. Hypoglycemic drugs affect the bone quality and the risk of fractures in patients with type 2 diabetes mellitus (T2DM). We aimed to investigate the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and insulin on bone mineral density (BMD) in T2DM. Methods. In this single-blinded study, a total of 65 patients with T2DM were randomly assigned into four groups for 52 weeks: the exenatide group ( n = 19 ), dulaglutide group ( n = 19 ), insulin glargine group ( n = 10 ), and placebo ( n = 17 ). General clinical data were collected, and BMD was measured by dual-energy X-ray absorptiometry. Results. Compared with baseline, the glycosylated hemoglobin (HbA1c) decreased significantly in the exenatide ( 8.11 ± 0.24 % vs. 7.40 ± 0.16 % , P = 0.007 ), dulaglutide ( 8.77 ± 0.37 % vs. 7.06 ± 0.28 % , P 〈 0.001 ), and insulin glargine ( 8.57 ± 0.24 % vs. 7.23 ± 0.25 % , P 〈 0.001 ) groups after treatment. In the exenatide group, the BMD of the total hip increased. In the dulaglutide group, only the BMD of the femoral neck decreased ( P = 0.027 ), but the magnitude of decrease was less than that in the placebo group; the BMD of L1-L4, femoral neck, and total hip decreased significantly ( P 〈 0.05 ) in the placebo group, while in the insulin glargine group, the BMD of L2, L4, and L1-4 increased ( P 〈 0.05 ). Compared with the placebo group, the BMD of the femoral neck and total hip in the exenatide group and the insulin glargine group were increased significantly ( P 〈 0.05 ); compared with the exenatide group, the BMD of L4 in the insulin glargine group was also increased ( P = 0.001 ). Conclusions. Compared with the placebo, GLP-1RAs demonstrated an increase of BMD at multiple sites of the body after treatment, which may not exacerbate the consequences of bone fragility. Therefore, GLP-1RAs might be considered for patients with T2DM. This trial is registered with ClinicalTrials.gov NCT01648582.
Type of Medium:
Online Resource
ISSN:
2314-6141
,
2314-6133
DOI:
10.1155/2021/3361309
Language:
English
Publisher:
Hindawi Limited
Publication Date:
2021
detail.hit.zdb_id:
2698540-8
Permalink